Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Cat Gr: Policy Research for HST -SPOR-Patient-Oriented Health Care Systems Res.

University of Calgary

$149,804.00

Addressing cost-related nonadherence of prescription medications through evidence-informed cost-sharing policies in public drug plans to advance health equity in Canada

FY 2022-23

Summary
Chronic diseases are a leading cause of death, but they can managed by medications and healthy behaviours. Despite these treatments, many Canadians suffer from chronic diseases when they can't afford their essential medications. This can add costs to the healthcare system, as these individuals can end up needing specialized healthcare in the hospital system. While many aspects of healthcare are covered for Canadians, medications prescribed outside of a hospital are not universally covered by provincial or territorial governments, resulting in variations across the country. A patchwork of employment benefits, private insurance, and public programs provides medication coverage for most Canadians, but many fall through the gaps when these benefits don't cover their costs. Our plan to address these shortfalls is to consider how patients are required to participate in cost-sharing (paying copayments, premiums or deductibles), and how these might affect their ability to take medications. We have come together with healthcare policy makers from across Canada to discuss how we can change policy to improve access to prescription medications for all. Our plan is to review existing medication plans across Canada and other similar countries, collect evidence from clinical trials examining providing medication coverage - including our team's own recent trial in Alberta. Once we develop policy options, we will host a virtual summit with everyone on our policy maker team across the country to refine and improve these options before we make our final recommendation to provincial and territorial governments. With the federal government's renewed commitment to national Pharmacare, along with new evidence from recent clinical trials, it is an ideal time to investigate how to best provide coverage to ensure all Canadians can afford essential, life-saving medications. A reworked policy will improve the long-term health of Canadians while saving healthcare funds for the future.
Program
Cat Gr: Policy Research for HST -SPOR-Patient-Oriented Health Care Systems Res.
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
475154
Name
Campbell David J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Policy Research for Health System Transformation
Projecttitle
Addressing cost-related nonadherence of prescription medications through evidence-informed cost-sharing policies in public drug plans to advance health equity in Canada
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$149,804
Cihrequipment2
$0
Programname2
Cat Gr: Policy Research for HST -SPOR-Patient-Oriented Health Care Systems Res.
Keyworddelim
Access To Medications; Cost-Related Non-Adherence; Cost-Sharing Mechanisms; Financial Barriers; Phamaceutical Policy; Pharmacare; Supplemental Health Insurance Benefits
Abstract
Chronic diseases are a leading cause of death, but they can managed by medications and healthy behaviours. Despite these treatments, many Canadians suffer from chronic diseases when they can't afford their essential medications. This can add costs to the healthcare system, as these individuals can end up needing specialized healthcare in the hospital system. While many aspects of healthcare are covered for Canadians, medications prescribed outside of a hospital are not universally covered by provincial or territorial governments, resulting in variations across the country. A patchwork of employment benefits, private insurance, and public programs provides medication coverage for most Canadians, but many fall through the gaps when these benefits don't cover their costs. Our plan to address these shortfalls is to consider how patients are required to participate in cost-sharing (paying copayments, premiums or deductibles), and how these might affect their ability to take medications. We have come together with healthcare policy makers from across Canada to discuss how we can change policy to improve access to prescription medications for all. Our plan is to review existing medication plans across Canada and other similar countries, collect evidence from clinical trials examining providing medication coverage - including our team's own recent trial in Alberta. Once we develop policy options, we will host a virtual summit with everyone on our policy maker team across the country to refine and improve these options before we make our final recommendation to provincial and territorial governments. With the federal government's renewed commitment to national Pharmacare, along with new evidence from recent clinical trials, it is an ideal time to investigate how to best provide coverage to ensure all Canadians can afford essential, life-saving medications. A reworked policy will improve the long-term health of Canadians while saving healthcare funds for the future.
Competitiondate
202210
Approvedterm2
1 yr 0 mth
Pinamesdelim
Campbell, David J; Mitchell, Chad
Approvedterm
1 an 0 mois
Cihrcontribution2
Patient Oriented Research~ $149,804~ $0~
University of Calgary - $149,804 Grant (2022-23) | Canada Spends